Premium Information is available for this item - Upgrade for $1 a day
6505-01-364-2272
Usp Zalcitabine Tablets
6505013642272 013642272 77255 NDC00004-0221-01
INC: 66774 Zalcitabine Tablets
January 2023
6
Marketplace 6505-01-364-2272
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-364-2272 5+ Documents (More...)
6505-01-364-2272 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2272
6505-01-364-2272 DEMIL: A | DEMILI : 1 | CRITICALITY : X | HMIC : P | PMIC : U | EDC: | ADPEC : 6505
6505/us 6505-01-364-2271 Usp Zalcitabine Tablets https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2272
364-2271Usp Zalcitabine Tablets6505013642271 013642271 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2272
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-4124 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2272
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-4125 Usp Zalcitabine Tablets 6505013644125,HIVID /77255
6505013642272,77255 fsg-65/fsc-6505/us 6505-01-364-4124 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-364-2272
013644125 HIVID NDC00004 7025-99 https 6505013642271,77252 6505-01-364-2271 Stock Numbers Related to 6505-01-364 -2272
Usp Zalcitabine Tablets 6505013642272,77255 6505-01-364-4124 6505-01-364-4125 6505-01-364-2272
JavaScript in your web browser . 7025-99-137-6200Power Supply And Fi7025991376200 99137620077255L A2/77255
Restrictions 6505-01-364-2272
6505-01-364-2272 is a Usp Zalcitabine Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-364-2272
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-364-2272
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-364-2272
- Part Number
- Manufacturer
- Status
- 77255
- Manufacturer
- 0PFX4 - Roche Laboratories Inc (Active)
- Primary Buy
- Primary Buy
- NDC00004-0221-01
- 0PFX4 - Roche Laboratories Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-364-2272
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Special Features [FEAT]
- 0.75 Mg;Oval;Film Coated
Similar Supply Items to 6505-01-364-2272
Freight Information 6505-01-364-2272
6505-01-364-2272 has freight characteristics.. 6505-01-364-2272 has a variance between NMFC and UFC when transported by rail and the description should be consulted.